William Blair & Company’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.38M | Sell |
108,904
-298
| -0.3% | -$15.1K | 0.01% | 505 |
|
|
2026
Q1 | $5.83M | Sell |
109,202
-648
| -0.6% | -$38.1K | 0.02% | 473 |
|
|
2025
Q4 | $6.83M | Sell |
109,850
-435
| -0.4% | -$26.9K | 0.02% | 441 |
|
|
2025
Q3 | $6.63M | Sell |
110,285
-1,242
| -1% | -$76K | 0.02% | 453 |
|
|
2025
Q2 | $6.99M | Buy |
111,527
+3,320
| +3% | +$200K | 0.02% | 423 |
|
|
2025
Q1 | $6.51M | Buy |
108,207
+6,263
| +6% | +$389K | 0.02% | 419 |
|
|
2024
Q4 | $5.95M | Sell |
101,944
-2,019
| -2% | -$120K | 0.02% | 451 |
|
|
2024
Q3 | $6.16M | Buy |
103,963
+893
| +0.9% | +$51K | 0.02% | 447 |
|
|
2024
Q2 | $5.78M | Buy |
103,070
+508
| +0.5% | +$28.4K | 0.02% | 448 |
|
|
2024
Q1 | $6.01M | Buy |
102,562
+1,519
| +2% | +$85.8K | 0.02% | 441 |
|
|
2023
Q4 | $5.45M | Buy |
101,043
+7,206
| +8% | +$352K | 0.02% | 441 |
|
|
2023
Q3 | $4.55M | Buy |
93,837
+8,244
| +10% | +$438K | 0.02% | 462 |
|
|
2023
Q2 | $4.83M | Buy |
85,593
+530
| +0.6% | +$29.2K | 0.02% | 459 |
|
|
2023
Q1 | $4.59M | Buy |
85,063
+3,815
| +5% | +$203K | 0.02% | 458 |
|
|
2022
Q4 | $4.27M | Buy |
81,248
+2,459
| +3% | +$125K | 0.02% | 459 |
|
|
2022
Q3 | $3.72M | Buy |
78,789
+2,987
| +4% | +$155K | 0.02% | 477 |
|
|
2022
Q2 | $3.82M | Buy |
75,802
+839
| +1% | +$45.7K | 0.02% | 483 |
|
|
2022
Q1 | $4.57M | Sell |
74,963
-1,633
| -2% | -$97.3K | 0.02% | 488 |
|
|
2021
Q4 | $5.04M | Buy |
76,596
+1,111
| +1% | +$71.1K | 0.02% | 474 |
|
|
2021
Q3 | $4.74M | Buy |
75,485
+671
| +0.9% | +$42.8K | 0.02% | 470 |
|
|
2021
Q2 | $4.5M | Buy |
74,814
+4,686
| +7% | +$271K | 0.02% | 480 |
|
|
2021
Q1 | $3.86M | Buy |
70,128
+1,596
| +2% | +$88.5K | 0.01% | 517 |
|
|
2020
Q4 | $3.74M | Buy |
68,532
+3,636
| +6% | +$190K | 0.01% | 497 |
|
|
2020
Q3 | $3.24M | Buy |
64,896
+1,542
| +2% | +$74.7K | 0.01% | 484 |
|
|
2020
Q2 | $2.8M | Buy |
63,354
+204
| +0.3% | +$8.72K | 0.01% | 490 |
|
|
2020
Q1 | $2.37M | Buy |
63,150
+360
| +0.6% | +$15.2K | 0.01% | 480 |
|
|
2019
Q4 | $2.77M | Buy |
62,790
+3,552
| +6% | +$149K | 0.01% | 534 |
|
|
2019
Q3 | $2.44M | Buy |
59,238
+3,312
| +6% | +$136K | 0.01% | 529 |
|
|
2019
Q2 | $2.24M | Sell |
55,926
-24
| -0% | -$908 | 0.01% | 543 |
|
|
2019
Q1 | $2.16M | Buy |
55,950
+7,794
| +16% | +$283K | 0.01% | 539 |
|
|
2018
Q4 | $1.6M | Buy |
48,156
+47,388
| +6,170% | +$1.64M | 0.01% | 578 |
|
|
2018
Q3 | $29K | Buy |
768
+138
| +22% | +$4.9K | ﹤0.01% | 1503 |
|
|
2018
Q2 | $21K | Sell |
630
-1,584
| -72% | -$51.6K | ﹤0.01% | 1492 |
|
|
2018
Q1 | $68K | Buy |
+2,214
| New | +$68.2K | ﹤0.01% | 1310 |
|
Other funds holding IHI
AAS
William Blair & Company's IHI Position: Q2 2026 in Review
William Blair & Company reduced its iShares US Medical Devices ETF (IHI) stake by 0.27% in Q2 2026, selling an estimated $15.1K and leaving 108,904 shares worth $5.38M. The position accounts for 0.01% of the portfolio, ranked #505.
William Blair & Company first reported a position in IHI in Q1 2018 and has held it in 34 quarters since. The position peaked at $6.99M in Q2 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- William Blair & Company held 108,904 shares of iShares US Medical Devices ETF worth $5.38M as of Q2 2026.
- William Blair & Company sold 298 iShares US Medical Devices ETF shares in Q2 2026, an estimated $15.1K.
- iShares US Medical Devices ETF made up 0.01% of William Blair & Company's portfolio in Q2 2026, its #505 holding.
- William Blair & Company first reported a position in iShares US Medical Devices ETF in Q1 2018 and has held it in 34 quarters since.
- William Blair & Company's iShares US Medical Devices ETF position peaked at $6.99M in Q2 2025.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.